Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Difficult-to-treat rheumatoid arthritis: an area of unmet clinical need.

de Hair MJH, Jacobs JWG, Schoneveld JLM, van Laar JM.

Rheumatology (Oxford). 2017 Oct 4. doi: 10.1093/rheumatology/kex349. [Epub ahead of print]

PMID:
29029308
2.

Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy.

Teitsma XM, Jacobs JWG, Welsing PMJ, Pethö-Schramm A, Borm MEA, Hendriks L, Denissen NHAM, van Laar JM, Lafeber FPJG, Bijlsma JWJ.

Rheumatology (Oxford). 2017 Sep 23. doi: 10.1093/rheumatology/kex319. [Epub ahead of print]

PMID:
29029185
3.

Do we need bone mineral density to estimate osteoporotic fracture risk? A 10-year prospective multicentre validation study.

Marques A, Lucas R, Simões E, Verstappen SMM, Jacobs JWG, da Silva JAP.

RMD Open. 2017 Sep 26;3(2):e000509. doi: 10.1136/rmdopen-2017-000509. eCollection 2017.

4.

Response to eLetter: 'Discussion of methotrexate dosage' by Maguire et al.

Safy M, Jacobs JWG, Ijff ND, Bijlsma JWJ, van Laar JM, de Hair MJH; Society for Rheumatology Research Utrecht (SRU).

Ann Rheum Dis. 2017 Oct 9. pii: annrheumdis-2017-212380. doi: 10.1136/annrheumdis-2017-212380. [Epub ahead of print] No abstract available.

PMID:
28993345
5.

Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy.

Teitsma XM, Jacobs JWG, Mokry M, Borm MEA, Pethö-Schramm A, van Laar JM, Bijlsma JWJ, Lafeber FPJ.

Arthritis Res Ther. 2017 Jul 20;19(1):170. doi: 10.1186/s13075-017-1378-x.

6.

A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement.

Rubbert-Roth A, Jacobs JWG, Bijlsma JWJ, Welsing PMJ.

Ann Rheum Dis. 2017 Jun 23. pii: annrheumdis-2017-211485. doi: 10.1136/annrheumdis-2017-211485. [Epub ahead of print] No abstract available.

PMID:
28646081
7.

Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors.

Lamers-Karnebeek FB, Luime JJ, Ten Cate DF, Teerenstra S, Swen NWAA, Gerards AH, Hendrikx J, van Rooyen EM, Voorneman R, Haagsma C, Basoski N, de Jager M, Ghiti Moghadam M, Efde MN, Goekoop-Ruiterman YPM, van Riel PLCM, Jacobs JWG, Jansen TL.

Rheumatology (Oxford). 2017 Sep 1;56(9):1560-1565. doi: 10.1093/rheumatology/kex184.

PMID:
28595367
8.

Can health care providers recognise a fibromyalgia personality?

Da Silva JAP, Jacobs JWG, Branco JC, Canaipa R, Gaspar MF, Griep EN, van Helmond T, Oliveira PJ, Zijlstra TJ, Geenen R.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):43-49. Epub 2017 Feb 23.

9.

Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.

Amann J, Wessels AM, Breitenfeldt F, Huscher D, Bijlsma JWJ, Jacobs JWG, Buttgereit F.

Clin Exp Rheumatol. 2017 May-Jun;35(3):471-476. Epub 2017 Jan 15.

PMID:
28094753
10.

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.

Bijlsma JWJ, Welsing PMJ, Woodworth TG, Middelink LM, Pethö-Schramm A, Bernasconi C, Borm MEA, Wortel CH, Ter Borg EJ, Jahangier ZN, van der Laan WH, Bruyn GAW, Baudoin P, Wijngaarden S, Vos PAJM, Bos R, Starmans MJF, Griep EN, Griep-Wentink JRM, Allaart CF, Heurkens AHM, Teitsma XM, Tekstra J, Marijnissen ACA, Lafeber FPJ, Jacobs JWG.

Lancet. 2016 Jul 23;388(10042):343-355. doi: 10.1016/S0140-6736(16)30363-4. Epub 2016 Jun 7.

PMID:
27287832
11.

Why do patients with rheumatoid arthritis use alternative treatments?

Jacobs JWG, Kraaimaat FW, Bijlsma JW.

Clin Rheumatol. 2001;20(3):192-6.

PMID:
11434472

Supplemental Content

Loading ...
Support Center